Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel N<sup>9</sup>-Substituted 6-Cycloalkylaminoadenines as Promising Compounds Against Triple Negative Breast Cancer.

Chemical biology & drug design·2026
Same author

Binding Mechanism of UAMC-1110 to Fibroblast Activation Protein.

Journal of chemical information and modeling·2026
Same author

Exploring cathepsin G inhibition by vinyl-based ionic liquids: Insights from lab-on-valve integrated microsequential analysis and molecular docking approaches.

Analytica chimica acta·2026
Same author

Design, synthesis, and in-vitro evaluation of 2-(heteroarylthio)acetamido-1<i>H</i>-benzo[<i>d</i>]imidazole derivatives as PTP1B inhibitors for the treatment of type 2 diabetes.

3 Biotech·2026
Same author

In Vitro Evaluation of the Potentiating Effects of Plant-Derived Molecules on Conventional Biocides.

Journal of visualized experiments : JoVE·2026
Same author

Aptamer-mediated outer membrane destabilization overcomes low permeability resistance in Pseudomonas aeruginosa.

The FEBS journal·2026

Related Experiment Video

Updated: Jun 15, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Virtual screening in drug design and development.

Sérgio F Sousa1, Nuno M F S A Cerqueira, Pedro A Fernandes

  • 1EQUIMTE, Departamento de Química, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.

Combinatorial Chemistry & High Throughput Screening
|March 19, 2010
PubMed
Summary

Virtual screening (VS) accelerates drug discovery by computationally identifying potential drug candidates from vast chemical libraries. This review details VS methodologies, stages, successes, and future challenges in drug development.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Related Experiment Videos

Last Updated: Jun 15, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Area of Science:

  • Computational Chemistry
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Virtual screening (VS) is integral to modern drug design and development.
  • It involves using computational methods to select promising drug candidates from large chemical libraries.
  • The definition of VS is broad, encompassing diverse methodologies.

Purpose of the Study:

  • To provide a comprehensive overview of the virtual screening process.
  • To highlight the importance of VS in the current drug discovery and development paradigm.
  • To analyze the stages, strengths, and limitations of VS campaigns.

Main Methods:

  • Review of existing literature and methodologies in virtual screening.
  • Categorization of different types of virtual screening approaches.
  • Analysis of case studies demonstrating VS success stories.

Main Results:

  • Detailed explanation of the virtual screening process and its various computational methodologies.
  • Identification of key stages within a VS campaign, including their respective strengths and limitations.
  • Presentation of selected successful applications of VS in drug discovery.

Conclusions:

  • Virtual screening is a crucial and evolving methodology in drug discovery.
  • Understanding VS stages and limitations is key to successful implementation.
  • Future challenges and opportunities in VS require continued research and development.